Sobi publishes report for the first quarter 2020
Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces its results for the first quarter 2020. Revenue growth for the quarter was 42 per cent with revenue of SEK 4,639 M. EBITA was SEK 2,173 M, resulting in an EBITA margin of 47 per cent for the quarter. January—March · Total revenue of SEK 4,639 M (3,265), 42 per cent revenue growth in the quarter compared with Q1 2019 (37 per cent at constant exchange rates (CER)) · EBITA[1] was SEK 2,173 M (1,509), an increase of 44 per cent · Earnings per share (EPS) of SEK 4.02 (3.14) · Net debt[1] of SEK 14,